Abstract

BackgroundMalignant acrospiroma is a rare tumor of the eccrine sweat glands accounting for around 6% of all malignant eccrine tumors. Typically, it presents as large ulcerated nodules, and diagnosis can be challenging as it has great overlap with its benign counterpart.Case presentationWe herein report a case of acral malignant acrospiroma, initially treated with surgical excision and adjuvant radiotherapy. After metastatic disease was confirmed, subject received multiple lines of chemo- as well as targeted therapy. Genomic testing was also done using next generation sequencing.ConclusionTo the best of our knowledge, this is the first case of acral malignant acrospiroma with reported next generation sequencing results.

Highlights

  • Malignant acrospiroma is a rare tumor of the eccrine sweat glands accounting for around 6% of all malignant eccrine tumors

  • Malignant acrospiromas arise from the intradermal duct of eccrine sweat glands and account for approximately 6% of malignant eccrine tumors [1] compared to their more prevalent benign counterparts [2]

  • They appear in the literature under multiple nomenclatures, including clear cell hidradenocarcinoma, malignant clear cell hidradenoma, and malignant hidradenoma [3, 4]

Read more

Summary

Introduction

Malignant acrospiroma is a rare tumor of the eccrine sweat glands accounting for around 6% of all malignant eccrine tumors. We report a case of acral malignant acrospiroma initially treated with surgical excision and adjuvant radiotherapy. We tested the tumor for genomic alterations using generation sequencing. Case presentation A 73-year-old White male was referred to our institution for the treatment of metastatic malignant acrospiroma.

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.